Valuation
- Market cap
- 65,000
- Revenue TTM
- $5,112,043
- Net income TTM
- $1,910,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 349,729
- Avg volume
- 140,396
- Day's range
- $0.00 – $0.00
- Shares out
- 31,160,000
- Stochastic %K
- 6%
- Beta
- 1.87
- Analysts
- Strong Sell
- Price target
- $25.00
Company profile
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 973 242 0005
- Website
- https://petrospharma.com
- Address
- 1185 Avenue of the Americas, 3rd Floor, New York, United States
Latest news
No headlines yet.
